Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ankyrin binding	SLC8A1 IQCJ-SCHIP1 PLEC	2.84e-05	23	52	3	GO:0030506
GeneOntologyMolecularFunction	transmembrane transporter binding	SLC8A1 HRC IQCJ-SCHIP1 RIMS1 EPN1	8.38e-05	172	52	5	GO:0044325
GeneOntologyMolecularFunction	calmodulin binding	SLC8A1 MYH10 CALD1 MYH14 IQCJ-SCHIP1	3.25e-04	230	52	5	GO:0005516
GeneOntologyCellularComponent	myosin II filament	MYH10 MYH14	1.82e-05	3	52	2	GO:0097513
GeneOntologyCellularComponent	supramolecular fiber	CCSAP SLC8A1 TFPT MYH10 CALD1 MYH14 CSNK1D HRC EIF3A PLEC PRPH	1.25e-04	1179	52	11	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	CCSAP SLC8A1 TFPT MYH10 CALD1 MYH14 CSNK1D HRC EIF3A PLEC PRPH	1.33e-04	1187	52	11	GO:0099081
GeneOntologyCellularComponent	myosin complex	MYH10 MYH14 CGNL1	4.28e-04	59	52	3	GO:0016459
Domain	Myosin_tail_1	MYH10 MYH14 CGNL1	1.35e-05	18	49	3	PF01576
Domain	Myosin_tail	MYH10 MYH14 CGNL1	1.35e-05	18	49	3	IPR002928
Domain	ABC_A	ABCA1 ABCA12	4.38e-04	12	49	2	IPR026082
Domain	Myosin_N	MYH10 MYH14	6.93e-04	15	49	2	IPR004009
Domain	Myosin_N	MYH10 MYH14	6.93e-04	15	49	2	PF02736
Domain	IQ	MYH10 MYH14 IQCE	8.56e-04	71	49	3	PF00612
Domain	Myosin-like_IQ_dom	MYH10 MYH14	1.12e-03	19	49	2	IPR027401
Domain	-	MYH10 MYH14	1.12e-03	19	49	2	4.10.270.10
Domain	IQ	MYH10 MYH14 IQCE	1.25e-03	81	49	3	SM00015
Domain	IQ_motif_EF-hand-BS	MYH10 MYH14 IQCE	1.70e-03	90	49	3	IPR000048
Domain	IQ	MYH10 MYH14 IQCE	1.87e-03	93	49	3	PS50096
Domain	MYOSIN_MOTOR	MYH10 MYH14	4.46e-03	38	49	2	PS51456
Domain	Myosin_head	MYH10 MYH14	4.46e-03	38	49	2	PF00063
Domain	Myosin_head_motor_dom	MYH10 MYH14	4.46e-03	38	49	2	IPR001609
Domain	MYSc	MYH10 MYH14	4.46e-03	38	49	2	SM00242
Domain	ABC_transporter_CS	ABCA1 ABCA12	5.43e-03	42	49	2	IPR017871
Domain	P-loop_NTPase	CACNB2 ABCA1 MYH10 MYH14 ABCA12 MCM2 AK7	6.31e-03	848	49	7	IPR027417
Domain	ABC_TRANSPORTER_2	ABCA1 ABCA12	7.04e-03	48	49	2	PS50893
Domain	ABC_tran	ABCA1 ABCA12	7.04e-03	48	49	2	PF00005
Domain	ABC_TRANSPORTER_1	ABCA1 ABCA12	7.33e-03	49	49	2	PS00211
Domain	ABC_transporter-like	ABCA1 ABCA12	7.62e-03	50	49	2	IPR003439
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	MYH10 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 EIF3A PLEC CCDC9 PRRC2B PRPH	5.97e-10	551	53	11	34728620
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MYH10 MAP7D1 RBM25 PAXBP1 SNW1 MYH14 CSNK1D MATR3 PEG3 RBM5 PLEC PDCD7 MIDEAS PRRC2B	1.17e-08	1371	53	14	36244648
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	MYH10 RBM25 ZNF219 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 EIF3A HDGFL2	2.35e-08	605	53	10	28977666
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	PAXBP1 SNW1 MYH14 ZC3H13 RBM5 PDCD7 HDGFL2	1.09e-07	251	53	7	31076518
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CRACD CACNB2 MYH10 MAP7D1 CALD1 MYH14 CSNK1D MATR3 EIF3A RIMS1 CGNL1 PLEC PRRC2B	1.66e-07	1431	53	13	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH10 MAP7D1 CALD1 ZNF608 MYH14 MATR3 RBM5 EIF3A RIMS1 PLEC HDGFL2 PRRC2B PRPH	1.81e-07	1442	53	13	35575683
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	MYH10 RBM25 SNW1 MYH14 MATR3 MCM2 EIF3A HDGFL2	3.37e-07	441	53	8	31239290
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	MYH14 ZC3H13 EIF3A PLEC ZZEF1 PRPH	4.15e-07	187	53	6	26460568
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MYH10 RBM25 PAXBP1 SNW1 MYH14 ZC3H13 MATR3 RBM5 MCM2 EIF3A	5.26e-07	847	53	10	35850772
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	MYH10 RBM25 CALD1 MYH14 ZC3H13 MATR3 MCM2 EIF3A PLEC HDGFL2	5.26e-07	847	53	10	35235311
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MYH10 RBM25 PAXBP1 SNW1 FBXO3 ZC3H13 MATR3 RBM5 PLEC PDCD7 PRPH	5.78e-07	1082	53	11	38697112
Pubmed	Laminin stimulates and guides axonal outgrowth via growth cone myosin II activity.	MYH10 MYH14	2.28e-06	2	53	2	15880105
Pubmed	Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition.	MYH10 MYH14	2.28e-06	2	53	2	22025714
Pubmed	Ablation of nonmuscle myosin II-B and II-C reveals a role for nonmuscle myosin II in cardiac myocyte karyokinesis.	MYH10 MYH14	2.28e-06	2	53	2	20861308
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TFPT MAP7D1 RBM25 ZNF219 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 MIDEAS HDGFL2	3.28e-06	1294	53	11	30804502
Pubmed	The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.	MYH10 SNW1 ZC3H13 MATR3 CCDC9	6.07e-06	169	53	5	23084401
Pubmed	IQCJ-SCHIP1, a novel fusion transcript encoding a calmodulin-binding IQ motif protein.	SCHIP1 IQCJ-SCHIP1	6.83e-06	3	53	2	17045569
Pubmed	Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family.	MYH10 MYH14	6.83e-06	3	53	2	14594953
Pubmed	Vertebrate nonmuscle myosin II isoforms rescue small interfering RNA-induced defects in COS-7 cell cytokinesis.	MYH10 MYH14	6.83e-06	3	53	2	15774463
Pubmed	Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.	MYH10 MYH14	6.83e-06	3	53	2	15177565
Pubmed	Characterization of three full-length human nonmuscle myosin II paralogs.	MYH10 MYH14	6.83e-06	3	53	2	24072716
Pubmed	Planar polarity of multiciliated ependymal cells involves the anterior migration of basal bodies regulated by non-muscle myosin II.	MYH10 MYH14	6.83e-06	3	53	2	20685736
Pubmed	Disease-associated mutations and alternative splicing alter the enzymatic and motile activity of nonmuscle myosins II-B and II-C.	MYH10 MYH14	6.83e-06	3	53	2	15845534
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MYH10 RBM25 ZC3H13 MATR3 MCM2 EIF3A PLEC	7.81e-06	477	53	7	31300519
Pubmed	Human transcription factor protein interaction networks.	TFPT MYH10 MAP7D1 RBM25 SNW1 ZNF608 MYH14 MATR3 EIF3A MIDEAS PRRC2B	8.43e-06	1429	53	11	35140242
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	MYH10 MATR3 MCM2 EIF3A PLEC EPN1 FERMT3	9.42e-06	491	53	7	22623428
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	ZC3H13 MATR3 EIF3A PLEC PDCD7 CCDC9 PRRC2B FERMT3	1.04e-05	701	53	8	30196744
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CRACD MYH10 SNW1 CALD1 MATR3 EIF3A CGNL1 HDGFL2 PRRC2B	1.07e-05	934	53	9	33916271
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	CRACD MYH10 RBM25 PAXBP1 SNW1 CALD1 HDGFL2	1.14e-05	506	53	7	30890647
Pubmed	ABCA12 regulates ABCA1-dependent cholesterol efflux from macrophages and the development of atherosclerosis.	ABCA1 ABCA12	1.36e-05	4	53	2	23931754
Pubmed	Cellular nonmuscle myosins NMHC-IIA and NMHC-IIB and vertebrate heart looping.	MYH10 MYH14	1.36e-05	4	53	2	18697221
Pubmed	Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of Ranvier.	SCHIP1 IQCJ-SCHIP1	1.36e-05	4	53	2	27979964
Pubmed	De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder.	MYH10 RIMS1	1.36e-05	4	53	2	25284784
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB2 MYH10 MAP7D1 ZNF219 SNW1 MATR3 RIMS1 PRRC2B FERMT3	1.37e-05	963	53	9	28671696
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	CRACD MYH10 RBM25 PAXBP1 SNW1 ZC3H13 MATR3 EIF3A	1.41e-05	731	53	8	29298432
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYH10 RBM25 MYH14 MATR3 EIF3A	1.44e-05	202	53	5	24639526
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MYH10 RBM25 SNW1 MATR3 RBM5 MCM2 EIF3A PLEC MIDEAS	1.69e-05	989	53	9	36424410
Pubmed	Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae.	CACNB2 SCHIP1 IQCJ-SCHIP1	1.93e-05	34	53	3	19197348
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RBM25 PAXBP1 ZC3H13 MATR3 MCM2 RIMS1 PLEC CCDC9	2.12e-05	774	53	8	15302935
Pubmed	CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.	SCHIP1 IQCJ-SCHIP1	2.27e-05	5	53	2	25950943
Pubmed	Myosin II regulates extension, growth and patterning in the mammalian cochlear duct.	MYH10 MYH14	2.27e-05	5	53	2	19439495
Pubmed	Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development.	MYH10 MYH14	2.27e-05	5	53	2	33871354
Pubmed	Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption.	MYH10 MYH14	2.27e-05	5	53	2	25006807
Pubmed	Schwannomin-interacting protein-1 isoform IQCJ-SCHIP-1 is a late component of nodes of Ranvier and axon initial segments.	SCHIP1 IQCJ-SCHIP1	2.27e-05	5	53	2	18550753
Pubmed	The DNA sequence and analysis of human chromosome 14.	RBM25 SNW1 MIDEAS AK7	2.55e-05	111	53	4	12508121
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	MYH10 RBM25 PAXBP1 SNW1 ZC3H13 MATR3 MCM2 EIF3A PLEC FERMT3	2.61e-05	1318	53	10	30463901
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CACNB2 MYH10 MYH14 MATR3 EIF3A PLEC ZZEF1 CCDC9	2.86e-05	807	53	8	30575818
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	RBM25 SNW1 ZC3H13 MATR3 RBM5 EIF3A CCDC9 PRRC2B	2.86e-05	807	53	8	22681889
Pubmed	USP45 and Spindly are part of the same complex implicated in cell migration.	CRACD MYH10 MYH14 EIF3A PLEC	2.97e-05	235	53	5	30258100
Pubmed	Nonmuscle myosin II regulation of lung epithelial morphology.	MYH10 MYH14	3.40e-05	6	53	2	22972683
Pubmed	A point mutation in the motor domain of nonmuscle myosin II-B impairs migration of distinct groups of neurons.	MYH10 MYH14	3.40e-05	6	53	2	15034141
Pubmed	Replacing nonmuscle myosin 2A with myosin 2C1 permits gastrulation but not placenta vascular development in mice.	MYH10 MYH14	3.40e-05	6	53	2	30044719
Pubmed	Interactome and Ubiquitinome Analyses Identify Functional Targets of Herpes Simplex Virus 1 Infected Cell Protein 0.	MYH10 CALD1 PLEC PRPH	3.94e-05	124	53	4	35516420
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TFPT MAP7D1 RBM25 ZNF219 ZNF608 PRPF40B ABCA12 ZZEF1 PRRC2B	4.35e-05	1116	53	9	31753913
Pubmed	A new role for the architecture of microvillar actin bundles in apical retention of membrane proteins.	MYH10 MYH14 PLEC	4.53e-05	45	53	3	22114352
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	MYH10 MAP7D1 PAXBP1 SNW1 FBXO3 MATR3 MCM2 EIF3A PLEC HDGFL2	4.75e-05	1415	53	10	28515276
Pubmed	Nonmuscle myosin II isoform and domain specificity during early mouse development.	MYH10 MYH14	4.76e-05	7	53	2	20679233
Pubmed	ZF21 is a new regulator of focal adhesion disassembly and a potential member of the spreading initiation center.	MYH10 MYH14 MATR3	4.84e-05	46	53	3	20890123
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MYH10 RBM25 SNW1 MYH14 ZC3H13 PLEC PRRC2B	5.80e-05	653	53	7	22586326
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SNW1 ZNF608 MATR3 RBM5 PLEC	5.95e-05	272	53	5	31010829
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	MYH10 MATR3 RBM5 EIF3A PLEC	6.16e-05	274	53	5	34244482
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	MYH10 RBM25 CALD1 MATR3 EIF3A PLEC HDGFL2	6.21e-05	660	53	7	32780723
Pubmed	SIK2 orchestrates actin-dependent host response upon Salmonella infection.	MYH10 CALD1 MYH14	6.23e-05	50	53	3	33947818
Pubmed	Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma.	MCM2 EIF3A	6.34e-05	8	53	2	24386425
Pubmed	Convergence and extrusion are required for normal fusion of the mammalian secondary palate.	MYH10 MYH14	6.34e-05	8	53	2	25848986
Pubmed	Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.	ABCA1 ABCA12	6.34e-05	8	53	2	24293640
Pubmed	Loss of cell adhesion causes hydrocephalus in nonmuscle myosin II-B-ablated and mutated mice.	MYH10 MYH14	6.34e-05	8	53	2	17429076
Pubmed	A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.	RBM25 MYH14 MCM2	6.61e-05	51	53	3	34316707
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	MAP7D1 RBM25 CALD1 CSNK1D INPP5B RBM5 MCM2 PLEC	6.97e-05	916	53	8	32203420
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PAXBP1 SNW1 CSNK1D MCM2 HDGFL2 CCDC9	7.82e-05	469	53	6	27634302
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	SNW1 MATR3 MIDEAS HDGFL2	7.84e-05	148	53	4	32538781
Pubmed	Sp1 phosphorylation by cyclin-dependent kinase 1/cyclin B1 represses its DNA-binding activity during mitosis in cancer cells.	MYH10 MYH14 PLEC	7.84e-05	54	53	3	22266860
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	RBM25 SNW1 MATR3 PRPH	8.92e-05	153	53	4	28225217
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RBM25 PAXBP1 SNW1 CALD1 ZC3H13 MATR3 MIDEAS HDGFL2	9.24e-05	954	53	8	36373674
Pubmed	Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.	MAP7D1 RBM25 SNW1 MATR3 EIF3A PRPH	9.50e-05	486	53	6	30940648
Pubmed	Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6.	MYH10 MATR3 MCM2 EIF3A PLEC EPN1 FERMT3	9.53e-05	707	53	7	19738201
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	MYH10 MAP7D1 RBM25 NRBP2 PAXBP1 ZC3H13 MATR3	1.00e-04	713	53	7	29802200
Pubmed	ABCA12 regulates insulin secretion from β-cells.	ABCA1 ABCA12	1.02e-04	10	53	2	32072744
Pubmed	A point mutation in Myh10 causes major defects in heart development and body wall closure.	MYH10 MYH14	1.02e-04	10	53	2	24825879
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	MYH10 RBM25 PAXBP1 SNW1 ZNF608 MYH14 CSNK1D MATR3 CCDC9	1.02e-04	1247	53	9	27684187
Pubmed	Global phosphoproteome of HT-29 human colon adenocarcinoma cells.	SNW1 MCM2 PLEC	1.02e-04	59	53	3	16083285
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	MYH10 MYH14 MATR3 MCM2 EIF3A PLEC	1.04e-04	494	53	6	26831064
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	MAP7D1 SNW1 FBXO3 CSNK1D MATR3 MCM2 EIF3A PRRC2B	1.07e-04	974	53	8	28675297
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MAP7D1 MYH14 PEG3 RBM5 EIF3A PLEC	1.07e-04	497	53	6	23414517
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MYH10 MAP7D1 RBM25 SNW1 CSNK1D ZC3H13 MATR3 EIF3A PLEC	1.08e-04	1257	53	9	36526897
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	CRACD MYH10 SNW1 CALD1 MCM2 PRPH	1.09e-04	498	53	6	36634849
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	CRACD MYH10 RBM25 MYH14 PLEC FERMT3	1.15e-04	503	53	6	36217030
Pubmed	A noncanonical PWI domain in the N-terminal helicase-associated region of the spliceosomal Brr2 protein.	SNW1 MATR3	1.24e-04	11	53	2	25849387
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	TFPT MYH10 MAP7D1 FBXO3 MCM2 EIF3A PLEC PRRC2B	1.32e-04	1005	53	8	19615732
Pubmed	14-3-3ε mediates the cell fate decision-making pathways in response of hepatocellular carcinoma to Bleomycin-induced DNA damage.	CALD1 MATR3 EIF3A	1.43e-04	66	53	3	23472066
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	MYH10 CALD1 MYH14 MATR3 PLEC	1.43e-04	328	53	5	23398456
Pubmed	Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.	CALD1 MCM2 HDGFL2 CCDC9 FERMT3	1.47e-04	330	53	5	21044950
Pubmed	Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.	MYH10 MYH14	1.49e-04	12	53	2	8424456
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	CRACD MYH10 MATR3	1.49e-04	67	53	3	29254152
Pubmed	PML Recruits TET2 to Regulate DNA Modification and Cell Proliferation in Response to Chemotherapeutic Agent.	MYH10 MYH14 PLEC	1.49e-04	67	53	3	29735542
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RBM25 SNW1 CALD1 MYH14 MATR3 MCM2 EIF3A PLEC	1.50e-04	1024	53	8	24711643
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	MYH10 MATR3 MCM2 EIF3A	1.63e-04	179	53	4	36261009
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	MYH10 RBM25 CALD1 MATR3 MIDEAS	1.69e-04	340	53	5	24332808
Pubmed	A Map of Human Mitochondrial Protein Interactions Linked to Neurodegeneration Reveals New Mechanisms of Redox Homeostasis and NF-κB Signaling.	CALD1 MYH14 MCM2 EIF3A PLEC HDGFL2 PRPH	1.83e-04	786	53	7	29128334
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RBM25 SNW1 CALD1 MATR3 MIDEAS PRRC2B	1.84e-04	549	53	6	38280479
Interaction	PRMT1 interactions	MYH10 NRBP2 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 MCM2 EIF3A PLEC CCDC9 PRRC2B PRPH	4.65e-07	929	52	13	int:PRMT1
Interaction	CIT interactions	MYH10 RBM25 PAXBP1 SNW1 FBXO3 MYH14 ZC3H13 MATR3 RBM5 EIF3A PLEC PDCD7 ZZEF1 HDGFL2 PRPH	2.35e-06	1450	52	15	int:CIT
Interaction	MEN1 interactions	MYH10 RBM25 PAXBP1 SNW1 ZNF608 MYH14 ZC3H13 MATR3 RBM5 MCM2 EIF3A MIDEAS	9.13e-06	1029	52	12	int:MEN1
Interaction	KIF20A interactions	MYH10 RBM25 PAXBP1 MYH14 CSNK1D INPP5B MATR3 EIF3A PLEC EPN1 PRRC2B PRPH	1.14e-05	1052	52	12	int:KIF20A
Interaction	OBSL1 interactions	IQCA1L MAP7D1 RBM25 SNW1 CALD1 CROCC2 MATR3 MCM2 EIF3A PLEC MIDEAS	1.52e-05	902	52	11	int:OBSL1
Interaction	MECP2 interactions	MYH10 RBM25 PAXBP1 SNW1 FBXO3 PRPF40B CSNK1D ZC3H13 MATR3 RBM5 PLEC PDCD7 PRPH	1.69e-05	1287	52	13	int:MECP2
Interaction	CHD3 interactions	MYH10 RBM25 ZNF219 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 MCM2 EIF3A	1.99e-05	757	52	10	int:CHD3
Interaction	RAD18 interactions	MYH10 PAXBP1 SNW1 MYH14 ZC3H13 RBM5 PDCD7 HDGFL2	2.06e-05	457	52	8	int:RAD18
Interaction	IFI27L1 interactions	RBM25 PAXBP1 SNW1 ZC3H13	2.37e-05	65	52	4	int:IFI27L1
Interaction	DDX23 interactions	MYH10 RBM25 PAXBP1 SNW1 ZC3H13 MATR3 RBM5 HDGFL2	2.93e-05	480	52	8	int:DDX23
Interaction	SNRNP40 interactions	RBM25 PAXBP1 SNW1 ZNF608 PRPF40B ZC3H13 RBM5 MIDEAS HDGFL2	3.25e-05	637	52	9	int:SNRNP40
Interaction	KCTD13 interactions	CRACD CACNB2 MYH10 MAP7D1 CALD1 MYH14 CSNK1D MATR3 EIF3A RIMS1 CGNL1 PLEC PRRC2B	3.91e-05	1394	52	13	int:KCTD13
Interaction	GAN interactions	MYH14 ZC3H13 EIF3A PLEC ZZEF1 PRPH	4.63e-05	253	52	6	int:GAN
Interaction	MAGOH interactions	MYH10 SNW1 ZC3H13 MATR3 MCM2 CCDC9	5.87e-05	264	52	6	int:MAGOH
Interaction	ACTC1 interactions	CRACD MYH10 RBM25 PAXBP1 SNW1 CALD1 MCM2 PLEC HDGFL2	6.31e-05	694	52	9	int:ACTC1
Interaction	ITGB3 interactions	MYH10 MCM2 EIF3A PLEC FERMT3	7.59e-05	170	52	5	int:ITGB3
Interaction	YAP1 interactions	MYH10 RBM25 SNW1 CALD1 MYH14 CSNK1D MATR3 EIF3A PLEC MIDEAS PRPH	8.95e-05	1095	52	11	int:YAP1
Interaction	CHD4 interactions	MYH10 RBM25 ZNF219 PAXBP1 SNW1 MATR3 RBM5 MCM2 EIF3A HDGFL2	1.21e-04	938	52	10	int:CHD4
Interaction	NEFM interactions	SCHIP1 MYH10 CALD1 MCM2 PLEC	1.28e-04	190	52	5	int:NEFM
Interaction	CTTN interactions	RBM25 SNW1 CALD1 CSNK1D MATR3 PLEC FERMT3	1.48e-04	450	52	7	int:CTTN
Interaction	MYCN interactions	MYH10 MAP7D1 PAXBP1 SNW1 MYH14 ZC3H13 MATR3 MIDEAS HDGFL2 CCDC9 PRRC2B PRPH	1.53e-04	1373	52	12	int:MYCN
Interaction	SNRNP200 interactions	PAXBP1 SNW1 MATR3 RBM5 MCM2 PDCD7 FERMT3	1.70e-04	460	52	7	int:SNRNP200
Interaction	NAA40 interactions	CRACD MYH10 SNW1 CALD1 MATR3 MCM2 EIF3A CGNL1 HDGFL2 PRRC2B	1.70e-04	978	52	10	int:NAA40
Interaction	NCAPG interactions	MYH10 RBM25 SNW1 MATR3 PLEC	1.71e-04	202	52	5	int:NCAPG
Interaction	SYDE2 interactions	CALD1 CSNK1D PLEC	1.86e-04	43	52	3	int:SYDE2
Interaction	AR interactions	MYH10 RBM25 PAXBP1 SNW1 ZNF608 MYH14 MATR3 MCM2 MIDEAS PRRC2B	1.91e-04	992	52	10	int:AR
Interaction	PAX8 interactions	FBXO3 ZNF608 MIDEAS PRRC2B	1.92e-04	111	52	4	int:PAX8
Interaction	DOT1L interactions	MYH10 RBM25 PAXBP1 SNW1 MYH14 ZC3H13 MATR3 RBM5 EIF3A	1.98e-04	807	52	9	int:DOT1L
Interaction	THOC1 interactions	PAXBP1 SNW1 ZC3H13 MCM2 ZZEF1	2.04e-04	210	52	5	int:THOC1
Interaction	RBM6 interactions	ASB18 SNW1 MATR3 PLEC	2.51e-04	119	52	4	int:RBM6
Interaction	ACTG2 interactions	MYH10 MCM2 PLEC	2.75e-04	49	52	3	int:ACTG2
Interaction	HERC2 interactions	MYH10 MAP7D1 RBM25 PAXBP1 MATR3 EIF3A PLEC	2.93e-04	503	52	7	int:HERC2
Interaction	DDX6 interactions	RBM25 CSNK1D MCM2 ZC2HC1C EIF3A PLEC PRPH	2.93e-04	503	52	7	int:DDX6
Interaction	GAGE5 interactions	RBM25 MYH14 ZC3H13	3.28e-04	52	52	3	int:GAGE5
Interaction	CDK9 interactions	MYH10 RBM25 SNW1 MYH14 CSNK1D ZC3H13 MATR3 PLEC	3.43e-04	685	52	8	int:CDK9
Interaction	RABL6 interactions	MYH10 RBM25 MYH14 HDGFL2	3.52e-04	130	52	4	int:RABL6
Interaction	ZC3H18 interactions	CRACD MYH10 RBM25 PAXBP1 SNW1 ZC3H13 MATR3 EIF3A FERMT3	3.67e-04	877	52	9	int:ZC3H18
Interaction	MYL12B interactions	MYH10 MYH14 MCM2 IQCE	4.42e-04	138	52	4	int:MYL12B
Interaction	USP11 interactions	MYH10 MYH14 MATR3 EIF3A MIDEAS PRRC2B PRPH	4.44e-04	539	52	7	int:USP11
Interaction	HDAC1 interactions	CCSAP MYH10 MAP7D1 RBM25 ZNF219 ZNF608 MYH14 MATR3 PLEC MIDEAS	4.63e-04	1108	52	10	int:HDAC1
Interaction	USP15 interactions	MYH10 RBM25 ZC3H13 MATR3 MCM2 RIMS1 FERMT3	4.80e-04	546	52	7	int:USP15
Interaction	ITGA4 interactions	MYH10 MATR3 MCM2 EIF3A PLEC EPN1 FERMT3	4.85e-04	547	52	7	int:ITGA4
Interaction	S100A4 interactions	MYH10 MYH14 MATR3 ZZEF1	5.19e-04	144	52	4	int:S100A4
Cytoband	14q24.3	RBM25 SNW1 ZC2HC1C MIDEAS	4.28e-06	93	53	4	14q24.3
Cytoband	Ensembl 112 genes in cytogenetic band chr14q24	RBM25 SNW1 ZC2HC1C MIDEAS	8.66e-05	200	53	4	chr14q24
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	TFPT MYH14 PEG3 HRC EPN1 CCDC9	2.45e-03	1192	53	6	chr19q13
GeneFamily	ATP binding cassette subfamily A	ABCA1 ABCA12	2.08e-04	14	28	2	805
GeneFamily	Myosin heavy chains	MYH10 MYH14	2.40e-04	15	28	2	1098
GeneFamily	Actins\|Deafness associated genes	MYH14 TMEM132E	1.32e-02	113	28	2	1152
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	CACNB2 RBM25 NRBP2 CALD1 ZC3H13 MATR3 PEG3 RBM5 EIF3A MARVELD3 PLEC	2.35e-06	797	51	11	gudmap_developingGonad_P2_epididymis_1000
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	CACNB2 MYH10 CALD1 MATR3 IQCJ-SCHIP1	1.65e-06	167	53	5	c4e321bb87512ea839f324c92c0f1afea891483f
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYH10 CALD1 PEG3 RIMS1	2.72e-06	185	53	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 SLC8A1 CALD1 ZNF608 IQCJ-SCHIP1	3.43e-06	194	53	5	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CACNB2 SLC8A1 CALD1 ZNF608 IQCJ-SCHIP1	3.43e-06	194	53	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Smooth_muscle-2\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CALD1 TMEM132E HRC RXRG PRPH	3.89e-06	199	53	5	2c5ad62919c64ea0242e0984bb9932d2d975f4e3
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCSAP SV2C ZC2HC1C FERMT3	3.75e-05	158	53	4	91d8c93af328c3bbebe1d8f019b94849ebc548c0
ToppCell	RV-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	CACNB2 CALD1 RIMS1 MARVELD3	3.94e-05	160	53	4	29c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	MYH10 CALD1 RIMS1 MARVELD3	4.03e-05	161	53	4	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	PND01-03-samps\|World / Age Group, Lineage, Cell class and subclass	SCHIP1 NRBP2 MYH14 PLEC	4.03e-05	161	53	4	1973b112d8d67aacc02751797d0148e7b53bfa66
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 CALD1 MCM2 RIMS1	4.13e-05	162	53	4	3f264263878af630921911c2b344ac56eb1e7099
ToppCell	Influenza_Severe-cDC\|World / Disease group and Cell class	CRACD CACNB2 MYH10 MATR3	4.34e-05	164	53	4	c984228f73b9aa1aaf948541f64f41ed874770cd
ToppCell	Influenza_Severe-cDC\|Influenza_Severe / Disease group and Cell class	CRACD CACNB2 MYH10 MATR3	4.55e-05	166	53	4	b40bdf0f7f381e25be61188e9f6c294d25a8b824
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	ABCA1 MYH14 IQCJ-SCHIP1 CGNL1	5.46e-05	174	53	4	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 PAXBP1 MATR3 PEG3	5.71e-05	176	53	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TMEM132E SV2C RIMS1 PRPH	6.50e-05	182	53	4	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 CALD1 PEG3 RIMS1	6.64e-05	183	53	4	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	ASB18 CACNB2 SLC8A1 CALD1	6.78e-05	184	53	4	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYH10 PEG3 RIMS1	6.92e-05	185	53	4	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NRBP2 MYH14 IQCJ-SCHIP1 CGNL1	7.22e-05	187	53	4	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	CRACD CACNB2 MYH10 CALD1	7.22e-05	187	53	4	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	CACNB2 SLC8A1 MYH10 RIMS1	7.37e-05	188	53	4	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB2 MYH14 HRC RXRG	7.37e-05	188	53	4	4db566f3f708e66730aa9e16f4d73d91dc534177
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNB2 MYH14 HRC RXRG	7.37e-05	188	53	4	6704b92991ad8c0a910e9f36cd33d00bd26dcb8f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 MYH10 CALD1 RIMS1	7.37e-05	188	53	4	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	ASK454-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH10 MYH14 ZZEF1 HDGFL2	7.52e-05	189	53	4	316c857dec9383823e09f966bca62d52d933b141
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD ASB18 MYH14 HRC	7.52e-05	189	53	4	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD ASB18 MYH14 HRC	7.52e-05	189	53	4	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 CALD1 EIF3A CGNL1	7.68e-05	190	53	4	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASB18 MYH14 HRC RXRG	7.83e-05	191	53	4	9d7d680da3979e256191b534ebd14c5383e0cf93
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASB18 MYH14 HRC RXRG	7.83e-05	191	53	4	543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCell	droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.83e-05	191	53	4	97fb4232417a39801e87725755fd16a57c250209
ToppCell	droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.83e-05	191	53	4	64070a309d7e3f6001272409ab9ce206d0e7d73f
ToppCell	droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.99e-05	192	53	4	1a0c25106ae08eac912a4edd5fc1a3ee776f69c2
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.99e-05	192	53	4	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.99e-05	192	53	4	f6a4e348406a852ace9fb21db8fbdff539217645
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	RBM25 RBM5 EIF3A PRRC2B	7.99e-05	192	53	4	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SCHIP1 CALD1 PDCD7 HDGFL2	7.99e-05	192	53	4	2dee0402e97e48157e0bc01bcc8034f1645dfb7b
ToppCell	facs-Aorta-Heart-3m\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATR3 PEG3 EIF3A FERMT3	7.99e-05	192	53	4	1ccc47792edf9ee23501c8e2165d11271636b66a
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD SLC8A1 MYH14 HRC	7.99e-05	192	53	4	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC8A1 ABCA1 MATR3 SV2C	8.15e-05	193	53	4	779276e775cb2492e8dd36436295a536084a6415
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ASB18 CACNB2 SLC8A1 IQCJ-SCHIP1	8.15e-05	193	53	4	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 SCHIP1 CALD1 CGNL1	8.15e-05	193	53	4	f27e2be497745098b5269aa799dd3d5f62d78ba7
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 SCHIP1 CALD1 CGNL1	8.15e-05	193	53	4	4ccf984baebbb13ae916727137ce593fda7514a2
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRBP2 MYH14 MARVELD3 CGNL1	8.15e-05	193	53	4	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	CRACD CACNB2 MYH10 CALD1	8.32e-05	194	53	4	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 MYH14 IQCJ-SCHIP1 CGNL1	8.49e-05	195	53	4	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD CACNB2 SLC8A1 HRC	8.65e-05	196	53	4	fba52a4b82086dbae9a55038bf44c4539be926f5
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRACD CACNB2 SLC8A1 HRC	8.65e-05	196	53	4	a582130862bee76c0385156a333bfdfc75cf218b
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSNK1D MATR3 PEG3 EIF3A	8.83e-05	197	53	4	5bc11aff92da2a0aca8473f997fe7a99f3cae75d
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 MYH10 CALD1	8.83e-05	197	53	4	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 MYH10 CALD1	8.83e-05	197	53	4	bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	CRACD CACNB2 MYH10 CALD1	8.83e-05	197	53	4	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA1 MYH14 IQCJ-SCHIP1 CGNL1	8.83e-05	197	53	4	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	RBM25 ZC3H13 RBM5 EIF3A	8.83e-05	197	53	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 CALD1 TMEM132E PRPH	8.83e-05	197	53	4	d1cb30ec4f3024541e9876c70bf63fe4d5c55bf1
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	CALD1 MYH14 HRC PRPH	8.83e-05	197	53	4	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 CALD1 HRC PRPH	8.83e-05	197	53	4	3f078be0b0f5e16edfb6d517beb20ac6178767f0
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 CALD1 IQCJ-SCHIP1	8.83e-05	197	53	4	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 MYH10 CALD1	9.00e-05	198	53	4	bd42c03e384e64f61b02618cf1a5440033bb04b2
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SLC8A1 MYH10 PEG3 RIMS1	9.00e-05	198	53	4	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 CALD1 IQCJ-SCHIP1	9.00e-05	198	53	4	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 MYH10 CALD1	9.18e-05	199	53	4	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNB2 SLC8A1 MYH10 CALD1	9.36e-05	200	53	4	a66449b22b39dd6987fc2c3ed160d24564234ced
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRACD ZNF608 SV2C RXRG	9.36e-05	200	53	4	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRACD ZNF608 RXRG PRPH	9.36e-05	200	53	4	8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1
ToppCell	Neuronal-Inhibitory-iA\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CRACD ZNF608 SV2C RXRG	9.36e-05	200	53	4	5ef4a3dc18a44292184a59ced916183c0699b01e
ToppCell	RV-03._Atrial_Cardiomyocyte\|RV / Chamber and Cluster_Paper	CACNB2 SLC8A1 MATR3	2.66e-04	105	53	3	49e16b11f16e83a7d17d162c14bce991201bcc2a
ToppCell	LV-03._Atrial_Cardiomyocyte\|LV / Chamber and Cluster_Paper	CACNB2 SLC8A1 TMEM132E	3.93e-04	120	53	3	3b77bd0e3630cdd45001cecf5e47660a90ebc92e
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Nptx2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TMEM132E RXRG PRPH	4.13e-04	122	53	3	1720756e0b3e8db14a9ccabe83f9b41689a4f754
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ASB18 CACNB2 SLC8A1	4.13e-04	122	53	3	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAXBP1 MYH14 CGNL1	4.97e-04	130	53	3	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	LV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	CACNB2 SLC8A1 TMEM132E	4.97e-04	130	53	3	a3e12984fb61311e49cc76c59f74f4dffc48faa1
ToppCell	21-Trachea-Immune-Immune\|Trachea / Age, Tissue, Lineage and Cell class	CCSAP HRC SV2C	5.43e-04	134	53	3	4f0465324cc5b443ebadb68aef63be79b74f6ff9
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-regulatory_T_cell\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CACNB2 ABCA12 PRRC2B	6.96e-04	146	53	3	7748277cf2f12e2930d4f5a22247ab9bc266a954
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RBM25 ABCA12 RBM5	7.10e-04	147	53	3	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ASB18 ABCA12 RIMS1	7.24e-04	148	53	3	df6bc387cad2f81520bd8bbd009c8e63225dbadb
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CCSAP MCM2 SV2C	7.39e-04	149	53	3	efa30fcd9370f98eb7445f295eb4d0305ff455c3
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH10 CALD1 MCM2	7.68e-04	151	53	3	32d35906f4b2bd46b173e87f2dec972eb5da87b3
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TMEM132E SV2C RXRG	7.82e-04	152	53	3	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	PND01-03-samps-Epithelial-Epithelial-non_alveolar\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CCSAP ZC2HC1C AK7	7.97e-04	153	53	3	fc0d2d50aa3b6b2772bbf3626c9df5c5e8d7d11e
ToppCell	PND01-03-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	CCSAP ZC2HC1C AK7	7.97e-04	153	53	3	2482247d9c39c7b99bb45fb9153442f64fd6012f
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC8A1 CROCC2 ZZEF1	8.13e-04	154	53	3	e65e4636646164610f33f7bbac0d879a3ea55986
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 HRC SV2C	8.13e-04	154	53	3	b6e982e341c6cfb6ff80a318078fcb10c36d182f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 HRC SV2C	8.13e-04	154	53	3	d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a
ToppCell	10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 CALD1 TMEM132E	8.43e-04	156	53	3	bb505f639dbcad2b788db62d6084c2cb4e884bec
ToppCell	PBMC-Mild-cDC_3\|Mild / Compartment, Disease Groups and Clusters	CCSAP PRPF40B CGNL1	8.75e-04	158	53	3	5fefab4831687cd8dd45f5cc84f681398069c3be
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	CRACD CACNB2 CALD1	8.75e-04	158	53	3	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MCM2 IQCJ-SCHIP1	8.91e-04	159	53	3	fd7db2f7328cfefdc3ada2af91006d5a91d137e1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CRACD CALD1 CROCC2	8.91e-04	159	53	3	2607b562903228274fbd96168ba826782fab0b53
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CRACD CALD1 CROCC2	8.91e-04	159	53	3	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MCM2 IQCJ-SCHIP1	8.91e-04	159	53	3	aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 MCM2 IQCJ-SCHIP1	8.91e-04	159	53	3	8bbdef1e927f3130b578d7d7c5ff38bbe06fab63
ToppCell	lymphoid-T_cell-pro-T_cell\|T_cell / Lineage, cell class and subclass	ZNF608 IQCJ-SCHIP1 MIDEAS	9.07e-04	160	53	3	66fe86d2f37983761141e5bb3de127f0b4bb0951
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	CACNB2 MYH10 CALD1	9.24e-04	161	53	3	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	severe_influenza-cDC\|severe_influenza / disease group, cell group and cell class (v2)	CRACD CACNB2 MATR3	9.24e-04	161	53	3	7716315b8bda904b346cea47edc2c0b507a345c2
ToppCell	facs-SCAT-Fat-18m-Epithelial-epithelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH14 ABCA12 MARVELD3	9.41e-04	162	53	3	7215f6eb2b65dea455e2eec722a9c38e6958b120
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 HRC RXRG	9.41e-04	162	53	3	5f009b231f21861afee9cc0c569082e1135f929c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CALD1 HRC RXRG	9.41e-04	162	53	3	b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCell	TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-7\|TCGA-Stomach / Sample_Type by Project: Shred V9	SCHIP1 RXRG PRPH	9.41e-04	162	53	3	b115b5799137122bd60696f8ae2aebadad6cd044
ToppCell	facs-SCAT-Fat-18m-Epithelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH14 ABCA12 MARVELD3	9.41e-04	162	53	3	7fa93efa2039d68a4e8214fa143bcd3368349a2d
Disease	HMG CoA reductase inhibitor use measurement	ABCA1 MARVELD3 PLEC FERMT3	3.22e-04	189	51	4	EFO_0009932
Disease	corpus callosum volume measurement	SCHIP1 IQCJ-SCHIP1 PLEC	6.99e-04	100	51	3	EFO_0010299
Disease	low density lipoprotein cholesterol measurement, response to escitalopram, response to citalopram	RIMS1 CGNL1	7.89e-04	24	51	2	EFO_0004611, EFO_0006329, EFO_0007871
Disease	C-reactive protein measurement	CACNB2 ABCA1 RBM25 NRBP2 ZNF608 MCM2 ZZEF1 AK7	1.01e-03	1206	51	8	EFO_0004458
Disease	right ventricular ejection fraction measurement	ABCA1 PLEC	1.24e-03	30	51	2	EFO_0021816
Disease	personality trait	TMEM132E RXRG	2.08e-03	39	51	2	EFO_0004365

Protein segments in the cluster

Peptide	Gene	Start	Entry
IDEDEDVRAERLRVE	ABCA12	2231	Q86UK0
EDEDVRRERQRILDG	ABCA1	1891	O95477
EEAERRARGAPEEQD	CCSAP	91	Q6IQ19
VSLEEDREAVRREAE	CACNB2	86	Q08289
RDREEDEEDAYERRK	RBM25	431	P49756
ELECAREGEEERRER	IQCE	431	Q6IPM2
RRQVERATEDGEEDE	MCM2	151	P49736
AREREREREDESEDE	NRBP2	11	Q9NSY0
DDRLRDGERCRDDSF	MATR3	221	P43243
RRGAEADARDEDERS	ASB18	281	Q6ZVZ8
DEDDEEERRRRVFDV	FBXO3	446	Q9UK99
EERERAEAEGREREA	MYH14	1486	Q7Z406
ERAREREAEREAEAA	PDCD7	251	Q8N8D1
REAEREAEAARAVER	PDCD7	256	Q8N8D1
ERDRVQVERDGLAED	PRPH	161	P41219
GASRAADDAERERRD	CSNK1D	296	P48730
RKRNDSEEEERERDE	PAXBP1	11	Q9Y5B6
ERERERRNSDRSEDG	RBM5	61	P52756
ERERARGDSEALDEE	HDGFL2	656	Q7Z4V5
DNEREHERERERERG	PEG3	591	Q9GZU2
VEGAVEERERKERRE	RIMS1	301	Q86UR5
GEGRDEDRSHRRDEE	EIF3A	921	Q14152
REENDKDPERERDRE	EIF3A	1216	Q14152
RRADDRKDDRVEERD	EIF3A	1311	Q14152
AELEDRLESEERDRA	CGNL1	1156	Q0VF96
AERGDVEREAERLRA	CROCC2	1021	H7BZ55
EESERDRREESRRHG	CCDC9	206	Q9Y3X0
LEERRRQEEEEGRCA	CRACD	341	Q6ZU35
DRDPERDQERDGNRD	MARVELD3	56	Q96A59
EARAEREAEARRREE	MAP7D1	641	Q3KQU3
EKEEQEEGRERSRRA	MIDEAS	951	Q6PJG2
REEHDKEERIRRGDD	EPN1	221	Q9Y6I3
GRSARDGRRDEELEE	INPP5B	226	P32019
RYAEERDRAEAEARE	MYH10	1466	P35580
RELESERRADEEELA	SV2C	121	Q496J9
EDEEEEERRQSASRG	TMEM132E	571	Q6IEE7
EEEEDERDQRGYRDD	SCHIP1	101	P0DPB3
IRRDEEQDGRIREDG	IQCA1L	186	A6NCM1
EEDEERREERAEVGA	HRC	546	P23327
EEEEEDERDQRGYRD	IQCJ-SCHIP1	176	B3KU38
DDDEEEAARERRRRA	CALD1	31	Q05682
AAAQERERREAEERE	CALD1	301	Q05682
GLRERDEEEEAARGR	TFPT	56	P0C1Z6
EEEERRAREERLAAC	PRRC2B	511	Q5JSZ5
EERQRSRERAESEAE	RXRG	211	P48443
EHIRALEREEEEERE	PRPF40B	466	Q6NWY9
LSTRERARGEELDED	FERMT3	641	Q86UX7
DGEARERDEIRHDRR	SNW1	346	Q13573
EAERAREEAERELER	PLEC	1756	Q15149
EFEEEFSRDRREDET	ZC2HC1C	291	Q53FD0
KATAEREREAERERD	ZNF608	1436	Q9ULD9
LELDERGDREEEVER	ZZEF1	2426	O43149
TVVEERVGEERERER	SMIM45	81	A0A590UK83
ARARRHRAEEPEEEE	ZNF219	416	Q9P2Y4
GRDDRREKREEIRED	ZC3H13	796	Q5T200
AEERLAREAAEEAER	AK7	626	Q96M32
EVDERDQDDEEARRE	SLC8A1	311	P32418